{"title":"The effect of high-power short-duration pulmonary vein isolation on PWPT-a predictor of paroxysmal atrial fibrillation.","authors":"Meng Wang, Xiaochen Wang, Feng Gao, Pei Bao, Zheng Huang","doi":"10.1007/s00059-023-05198-y","DOIUrl":"10.1007/s00059-023-05198-y","url":null,"abstract":"<p><strong>Background: </strong>The P wave peak time (PWPT) is a predictor of paroxysmal atrial fibrillation (PAF). High-power short-duration ablation has been associated with improved durability of circumferential pulmonary vein electrical isolation (PVI). We investigated the effect of high-power short-duration PVI on PWPT in patients with PAF.</p><p><strong>Methods: </strong>Out of 111 patients with PAF, 91 received radiofrequency ablation (ablation group) and 20 received medication treatment (control group). A VIZIGO sheath and an STSF catheter (Biosense Webster, CA, USA) were used together for high-power short-duration circumferential PVI at ablation index values of 500 and 400 for the anterior and posterior walls, respectively. The patients were followed up for 12 months.</p><p><strong>Results: </strong>The preoperative PWPT in the ablation group was similar to that in the control group: PWPT II = 54.38 ± 6.18 ms vs. 54.35 ± 6.12 ms (p > 0.05), PWPT V<sub>1</sub> = 54.19 ± 6.21 ms vs. 54.31 ± 6.08 ms (p > 0.05), respectively. Circumferential PVI was achieved for all patients in the ablation group during the operation. At the 12-month follow-up, there were seven cases of AF recurrence. The PWPT in the ablation group 12 months postoperatively was shorter than the preoperative value: PWPT II = 49.39 ± 7.11 ms vs. 54.38 ± 6.18 ms (p < 0.001), PWPT V<sub>1</sub> = 47.69 ± 7.01 ms vs. 54.19 ± 6.21 ms (p < 0.001). The PWPT in the patients with AF recurrence was significantly longer than that in the non-recurrence patients: PWPT II = 50.48 ± 7.12 ms vs. 47.33 ± 6.21 ms (p < 0.001), PWPT V<sub>1</sub> = 50.84 ± 7.05 ms vs. 47.19 ± 6.27 ms, (p < 0.001). The PWPT of the control group at the 12-month follow-up was similar to the baseline level: PWPT II = 54.32 ± 6.20 ms vs. 54.35 ± 6.12 ms (p > 0.05), PWPT V<sub>1</sub> = 53.89 ± 6.01 ms vs. 54.31 ± 6.08 ms (p > 0.05).</p><p><strong>Conclusion: </strong>The results showed that high-power short-duration PVI had a positive effect on PWPT, which is a predictor of PAF.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"69-74"},"PeriodicalIF":1.7,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9870897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-02-01Epub Date: 2023-12-05DOI: 10.1007/s00059-023-05224-z
Noemi Pavo, Christian Hengstenberg
{"title":"[Management of cardiomyopathies : New ESC guidelines 2023].","authors":"Noemi Pavo, Christian Hengstenberg","doi":"10.1007/s00059-023-05224-z","DOIUrl":"10.1007/s00059-023-05224-z","url":null,"abstract":"<p><p>The group of cardiomyopathies has received increasing attention over the last few years after some of the causes were identified and they could be characterized more exactly using modern imaging methods. New definitions and classification schemes were regularly provided by national and international cardiac societies. The new guidelines of the European Society of Cardiology (ESC) from 2023 on the management of cardiomyopathies are the first guidelines that comprehensively address all cardiomyopathies in one document. As these are new guidelines most of the recommendations are also new. An exception is the section on hypertrophic cardiomyopathy (HCM), which provides a targeted update of the 2014 ESC guidelines on the diagnosis and treatment of HCM. The main aim of the guidelines is to provide clear guidance for the diagnosis of cardiomyopathies, to highlight general assessment and management problems and to point out the relevant scientific evidence for the recommendations to the readership. Due to the magnitude detailed descriptions and recommendations cannot be provided for each individual cardiomyopathy phenotype; however, reference is made to the relevant literature.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"22-32"},"PeriodicalIF":1.7,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10830601/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138487380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2023-12-18DOI: 10.1007/s00059-023-05226-x
Bernhard Maisch
{"title":"Kanadas Leitlinienempfehlung zu Alkohol und Gesundheit","authors":"Bernhard Maisch","doi":"10.1007/s00059-023-05226-x","DOIUrl":"https://doi.org/10.1007/s00059-023-05226-x","url":null,"abstract":"<p>Alkohol ist ein gesellschaftlich anerkanntes Genuss- und Nahrungsmittel und ist als Kulturgut auch Bestandteil religiöser Rituale. Er ist auch ein Rauschmittel und ebenso auch ein Suchtmittel. Außerdem ist er eine Noxe, denn weltweit sterben pro Jahr rund 3 Mio. Menschen an den Folgen des Alkoholkonsums. Mit der Veröffentlichung von Zhao et al. 2023 wurde die Beziehung zwischen Alkoholmenge und Mortalität in den Empfehlungen der Canada’s Guidance on Alcohol and Health neu sortiert. Aus der J‑Kurve des „French paradox“ wurde eine lineare Beziehung zwischen Alkoholkonsum und Mortalität, weil sich bei der Überprüfung mehrerer Kontrollgruppen ein Rekrutierungsfehler aus abstinent gewordenen Extrinkern herausgestellt hatte. In ihrer systematischen Analyse bei Berücksichtigung dieses Bias musste die Bewertung geringer Mengen Alkohols als kardioprotektives Genussmittel revidiert werden. Dies ist ein Paradigmenwechsel.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":"79 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138717601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2023-12-01Epub Date: 2023-10-13DOI: 10.1007/s00059-023-05214-1
Uwe Zeymer, Janine Pöss, Ralf Zahn, Holger Thiele
{"title":"[Prehospital resuscitation : Current status, results and strategies for improvement in Germany].","authors":"Uwe Zeymer, Janine Pöss, Ralf Zahn, Holger Thiele","doi":"10.1007/s00059-023-05214-1","DOIUrl":"10.1007/s00059-023-05214-1","url":null,"abstract":"<p><p>Out-of-hospital cardiac arrest (OHCA) is one of the most frequent causes of death in Europe and is associated with a dismal prognosis. The annual incidence in Germany is approximately 100-120 per 100,000 inhabitants (ca. 80,000-100,000 cases). With the use of cardiopulmonary resuscitation (CPR) about 40% of patients have a return of spontaneous circulation (ROSC); however, after OHCA only 15% of patients survive for 30 days and less than 10% survive with no or only minor neurological deficits. Data from the German Resuscitation Register demonstrate that there was no change in the results over the last 15 years, despite all medical innovations, higher rates of coronary interventions, higher use of mechanical support systems and improvement in intensive care treatment. A high proportion of patients with OHCA have a cardiac or coronary cause. As shown by the data from the German Cardiac Arrest Register (G-CAR) an early coronary angiography is often carried out after CPR in Germany; however, in randomized clinical studies an immediate coronary angiography in patients with non-ST segment elevation in the electrocardiogram (ECG) was not associated with an improvement in the prognosis. In large randomized studies the use of mechanical CPR systems and the implantation of mechanical circulatory support devices after OHCA also did not lead to a reduction in mortality. The most important impact factor for the success of CPR is the time interval between collapse and start of CPR, if possible also by bystander resuscitation. Therefore, the focus of efforts for improving CPR should be on increasing the rate of patients with early CPR. Experiences from Denmark and The Netherlands indicate that this can be successful by education and training of the general population, telephone resuscitation and apps for alerting lay persons.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"456-461"},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41199069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2023-12-01Epub Date: 2023-11-29DOI: 10.1007/s00059-023-05217-y
Ralf Zahn, Karl Werdan
{"title":"[Cardiological care research].","authors":"Ralf Zahn, Karl Werdan","doi":"10.1007/s00059-023-05217-y","DOIUrl":"10.1007/s00059-023-05217-y","url":null,"abstract":"","PeriodicalId":12863,"journal":{"name":"Herz","volume":"48 6","pages":"425"},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138451364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2023-12-01Epub Date: 2023-10-15DOI: 10.1007/s00059-023-05216-z
Volker Schächinger, Dirk Elmhorst, Ralf Zahn, Christian Perings, Christoph Stellbrink, Kurt Bestehorn
{"title":"Healthcare provision of transcatheter aortic valve implantation in Germany.","authors":"Volker Schächinger, Dirk Elmhorst, Ralf Zahn, Christian Perings, Christoph Stellbrink, Kurt Bestehorn","doi":"10.1007/s00059-023-05216-z","DOIUrl":"10.1007/s00059-023-05216-z","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter aortic valve implantation (TAVI) for aortic stenosis in older patients is the standard of care with a well-established supply density in Germany. In the near future, healthcare reform is planned that may affect TAVI capacities. Therefore, it is important to know how political regulations may interfere with access to services and what the need for TAVI will be in the future, based on demographic trends.</p><p><strong>Methods: </strong>The number of TAVI procedures (DRG F98A +F98) and the in-hospital main diagnoses of aortic stenosis (ICD I35) in 2021 were analyzed at the level of county or federal state based on anonymized data from hospital reports, according to § 21 of the German hospital reimbursement law. The number of TAVI and aortic stenosis cases was projected for 2035 based on data from the German Federal Statistical Office on demographic developments. With quality assurance data from hospitals in 2019 and a route planner, the travel time to the next hospital performing TAVI (OPS 5‑35a.0) was calculated, and the consequence of a politically suggested minimum volume cut-off was analyzed.</p><p><strong>Results: </strong>In 2021, a total of 26,506 TAVI procedures were reported with a mean number of TAVI per 100,000 inhabitants of 32 (range between federal states from 25 to 42). Among the 66,045 diagnoses of aortic stenosis, there was a variation per 100,000 inhabitants from 64 to 108 (mean 79) between federal states. Compared to 2021, an additional 8748 (+13%) diagnoses of aortic stenosis and an increase of 4673 (+18%) TAVI procedures is to be expected in 2035. In 2019, 57% of German citizens could reach a TAVI hospital within 30 min and 91% within 60 min of driving time by car (mean time to hospital 31 min). Applying a minimum number of 150 TAVI/hospital per year would increase the driving time to hospital from 33 to 52 min in Saxony-Anhalt and instantly remove six out of eight hospitals from service in Hesse.</p><p><strong>Conclusion: </strong>Regulation of TAVI services by minimum volume numbers would arbitrarily interfere with access to services, in contradiction to the medical service assurance tasks of federal state governments. These issues should be considered in the upcoming healthcare system reform.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"426-436"},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41234617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2023-12-01Epub Date: 2023-08-04DOI: 10.1007/s00059-023-05192-4
Lei Zhang, Xiao Li, Yixiu Liang, Jingfeng Wang, Minghui Li, Lei Pan, Xueying Chen, Shengmei Qin, Jin Bai, Wei Wang, Yangang Su, Junbo Ge
{"title":"Real-world evidence for the use of subcutaneous implantable cardioverter-defibrillators in China: A single-center experience.","authors":"Lei Zhang, Xiao Li, Yixiu Liang, Jingfeng Wang, Minghui Li, Lei Pan, Xueying Chen, Shengmei Qin, Jin Bai, Wei Wang, Yangang Su, Junbo Ge","doi":"10.1007/s00059-023-05192-4","DOIUrl":"10.1007/s00059-023-05192-4","url":null,"abstract":"<p><strong>Background: </strong>Subcutaneous implantable cardioverter-defibrillators (S-ICDs) have been shown to be non-inferior to transvenous ICDs in the prevention of sudden cardiac death (SCD), but there is still a lack of evidence from clinical trials in China. We investigated whether S‑ICD implantation in the Chinese population is safe and feasible and should be promoted in the future.</p><p><strong>Methods: </strong>Consecutive patients undergoing S‑ICD implantation at our center were enrolled in this retrospective study. Data were collected within the median follow-up period of 554 days. Data concerning patient selection, implantation procedures, complications, and episodes of shock were analyzed.</p><p><strong>Results: </strong>In total, 70.2% of all 47 patients (median age = 39 years) were included for secondary prevention of SCD with different etiologies. Vector screening showed that 98% of patients were with > 1 appropriate vector in all postures. An intraoperative defibrillation test was not performed on six patients because of the high risk of disease deterioration, while all episodes of ventricular fibrillation induced post implantation were terminated by one shock. As expected, no severe complications (e.g., infection and device-related complications) were observed, except for one case of delayed healing of the incision. Overall, 15 patients (31.9%) experienced appropriate shocks (AS) with all episodes terminated by one shock. Two patients (4.3%) experienced inappropriate shocks (IAS) due to noise oversensing, resulting in a high Kaplan-Meier IAS-free rate of 95.7%.</p><p><strong>Conclusion: </strong>Based on appropriate patient selection and standardized implantation procedures, this real-world study confirmed the safety and efficacy of S‑ICD in Chinese patients, indicating that it may help to promote the prevention of SCD in China.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"462-469"},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10291576","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2023-12-01Epub Date: 2023-11-06DOI: 10.1007/s00059-023-05215-0
Janet-Jacqueline Olic, Andrea Baessler, Marcus Fischer
{"title":"[Chest pain and cardiovascular diseases in women : Diagnostics and treatment].","authors":"Janet-Jacqueline Olic, Andrea Baessler, Marcus Fischer","doi":"10.1007/s00059-023-05215-0","DOIUrl":"10.1007/s00059-023-05215-0","url":null,"abstract":"<p><p>Cardiovascular diseases (CVD) are the leading cause of global mortality not only in men but also in women. The incidence of CVD significantly increases in women, especially after the menopause. Sex and gender differences in the incidence, prevalence and mortality of CVD are due to hormonal, anatomical, and sociocultural differences. As part of the primary and secondary prevention of coronary heart disease (CHD), risk factors specific for women, such as autoimmune diseases and pregnancy-associated diseases (e.g., gestational diabetes and pre-eclampsia) should also be taken into account in addition to the classical cardiovascular risk factors. Furthermore, in women with angina pectoris it should be considered that women in particular frequently suffer from ischemia with nonobstructive coronary arteries (INOCA) that can be caused, for example, by coronary microvascular dysfunction (CMD) or coronary spasms. Based on this, the diagnostics should not be terminated in symptomatic women after coronary angiography with normal epicardial vessels. A targeted diagnostics for CMD and coronary spasms should be carried out at an early stage.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"487-498"},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71480774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2023-12-01Epub Date: 2023-10-13DOI: 10.1007/s00059-023-05212-3
Miriam Puls
{"title":"[Mitral valve transcatheter edge-to-edge repair (M-TEER) in Germany : Treatment reality, potential needs, possible quality indicators and open questions].","authors":"Miriam Puls","doi":"10.1007/s00059-023-05212-3","DOIUrl":"10.1007/s00059-023-05212-3","url":null,"abstract":"<p><p>In 2020 in Germany, 21,753 patients were hospitalized with the main diagnosis of mitral valve regurgitation (MR), whereby 6050 isolated mitral valve (MV) operations, 4977 combined MV operations and 6011 transcatheter MV interventions were performed. In the last 10 years there was a nearly linear increase of MR-related hospitalizations and transcatheter MV interventions, whereas the numbers of isolated MV operations remained stable and the number of combined MV operations decreased. Due to demographic change and age distribution of MR patients, an increased need for minimally invasive transcatheter MV procedures can be expected in the future. In 2020 the 6011 transcatheter MV interventions were performed at approximately 180 centers in Germany. According to a retrospective analysis of diagnosis-related groups (DRG) hospital data up to 2017, two thirds of all 158 centers which provided transcatheter MV repair in Germany at that time carried out no more than 25 procedures per year. A significant correlation between hospital intervention volume and intrahospital mortality has not yet been found for transcatheter MV repair; however, registry data from Germany, Italy and the USA consistently confirm that centers with a high intervention volume achieve a better reduction of mitral regurgitation, which could directly translate into long-term survival. Thresholds of 20 or 50 procedures per year were suggested as predictive for a better procedural result in terms of MR reduction. Such analyses should be implemented in considerations regarding the appropriate number of transcatheter MV centers for Germany.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"437-447"},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41199068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2023-12-01Epub Date: 2023-10-13DOI: 10.1007/s00059-023-05213-2
Philipp M Doldi, Lukas Stolz, Ludwig T Weckbach, Jörg Hausleiter
{"title":"[T-TEER: description of a development process].","authors":"Philipp M Doldi, Lukas Stolz, Ludwig T Weckbach, Jörg Hausleiter","doi":"10.1007/s00059-023-05213-2","DOIUrl":"10.1007/s00059-023-05213-2","url":null,"abstract":"<p><p>Tricuspid valve regurgitation (TR) is becoming increasingly more clinically important. While considered as an accompanying symptom of left heart pathologies in the past, TR is now seen as an independent and clinically significant condition. TR can lead to volume overload of the right ventricle, resulting in dilatation of the tricuspid valve annulus and worsening of the regurgitation. Undetected or untreated severe TR can lead to recurrent cardiac decompensation with hospitalization, reduced quality of life and death. Previous treatment options were limited to cardiac surgery and associated with high complication and mortality rates, especially in isolated TR. Therefore, many patients are considered inoperable so that the new interventional treatment measures nowadays often represent the only treatment option. Interventional treatment options such as the edge-to-edge procedure (T-TEER) with TriClip™ or the PASCAL™ system are very safe interventions that have already shown promising results, including reduction of TR, improvement in heart failure symptoms and the quality of life. The influence on the mortality and the necessity for hospitalization due to heart failure are currently being investigated in several randomized studies. Patient selection and timing of the intervention are crucial. Cardiovascular imaging plays a decisive role in selecting the appropriate method and timing of the intervention. The prognosis depends on factors, such as the severity of TR, right ventricular dysfunction, and pulmonary arterial hypertension. Overall, interventional TR treatment is a promising advancement in treatment from which many patients can benefit in the future.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"448-455"},"PeriodicalIF":1.7,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41199070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}